Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major

[1]  V. Positano,et al.  Myocardial T2 values at 1.5 T by a segmental approach with healthy aging and gender , 2022, European Radiology.

[2]  G. Sinagra,et al.  [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.

[3]  J. McMurray,et al.  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. , 2021, European heart journal.

[4]  R. de Caterina,et al.  Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications , 2021, Journal of Cardiovascular Magnetic Resonance.

[5]  N. Martini,et al.  Myocardial T1 Values at 1.5 T: Normal Values for General Electric Scanners and Sex‐Related Differences , 2021, Journal of magnetic resonance imaging : JMRI.

[6]  P. Kellman,et al.  Females have higher myocardial perfusion, blood volume and extracellular volume compared to males – an adenosine stress cardiovascular magnetic resonance study , 2020, Scientific Reports.

[7]  S. Piechnik,et al.  CMR Parametric Mapping as a Tool for Myocardial Tissue Characterization , 2020, Korean circulation journal.

[8]  V. Positano,et al.  Biventricular Reference Values by Body Surface Area, Age, and Gender in a Large Cohort of Well‐Treated Thalassemia Major Patients Without Heart Damage Using a Multiparametric CMR Approach , 2020, Journal of magnetic resonance imaging : JMRI.

[9]  A. Angelini,et al.  CMR for myocardial iron overload quantification: calibration curve from the MIOT Network , 2020, European Radiology.

[10]  Jeroen J. Bax,et al.  2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). , 2019, European heart journal.

[11]  M. Dweck,et al.  Myocardial fibrosis: why image, how to image and clinical implications , 2019, Heart.

[12]  L. Janani,et al.  The effect of quercetin on iron overload and inflammation in β-thalassemia major patients: A double-blind randomized clinical trial. , 2019, Complementary therapies in medicine.

[13]  D. Katritsis.  Abstracts of the Annual Spring Meeting 2017 of the European Congenital Heart Surgeons Association, Leicester, UK, 19-20th May, 2017 , 2017, Cardiology in the Young.

[14]  V. Positano,et al.  MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine , 2018, British journal of haematology.

[15]  V. Positano,et al.  Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron , 2018, European Radiology.

[16]  A. Greiser,et al.  Association between myocardial extracellular volume and strain analysis through cardiovascular magnetic resonance with histological myocardial fibrosis in patients awaiting heart transplantation , 2018, Journal of Cardiovascular Magnetic Resonance.

[17]  V. Positano,et al.  Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach , 2018, European heart journal cardiovascular Imaging.

[18]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[19]  J. Towbin,et al.  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia. , 2017, Blood.

[20]  G. Hindricks,et al.  CMR-Derived Extracellular Volume Fraction as a Marker for Myocardial Fibrosis: The Importance of Coexisting Myocardial Inflammation. , 2017, JACC. Cardiovascular imaging.

[21]  D. Pennell,et al.  Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging , 2017, Hematology.

[22]  S. Plein,et al.  Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.

[23]  M. Jolly,et al.  Quantification of Myocardial Extracellular Volume Fraction with Cardiac MR Imaging in Thalassemia Major. , 2016, Radiology.

[24]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[25]  S. K. White,et al.  Noncontrast myocardial T1 mapping using cardiovascular magnetic resonance for iron overload , 2015, Journal of magnetic resonance imaging : JMRI.

[26]  J. Townend,et al.  Diffuse interstitial fibrosis and myocardial dysfunction in early chronic kidney disease. , 2015, The American journal of cardiology.

[27]  V. Positano,et al.  Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major. , 2014, International journal of cardiology.

[28]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[29]  Sebastian Kelle,et al.  Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI , 2013, Current cardiology reviews.

[30]  D. Pennell,et al.  Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. , 2013, Circulation.

[31]  V. Positano,et al.  Are the preferential patterns of myocardial iron overload preserved at the CMR follow-up? , 2012, Journal of Cardiovascular Magnetic Resonance.

[32]  Dudley J Pennell,et al.  On T2* Magnetic Resonance and Cardiac Iron , 2011, Circulation.

[33]  Massimo Lombardi,et al.  Single region of interest versus multislice T2* MRI approach for the quantification of hepatic iron overload , 2011, Journal of magnetic resonance imaging : JMRI.

[34]  V. Positano,et al.  Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients , 2010, Magnetic resonance in medicine.

[35]  Massimo Midiri,et al.  Multicenter validation of the magnetic resonance t2* technique for segmental and global quantification of myocardial iron , 2009, Journal of magnetic resonance imaging : JMRI.

[36]  P. Moraitis,et al.  The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[37]  V. Positano,et al.  Myocardial scarring by delayed enhancement cardiovascular magnetic resonance in thalassaemia major , 2009, Heart.

[38]  D J Pennell,et al.  Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major , 2009, Circulation.

[39]  T. Coates,et al.  Longitudinal analysis of heart and liver iron in thalassemia major. , 2008, Blood.

[40]  Matthew W. Darlison,et al.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[41]  Massimo Midiri,et al.  Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts , 2007, NMR in biomedicine.

[42]  V. Positano,et al.  Evaluation of the efficacy of oral deferiprone in β‐thalassemia major by multislice multiecho T2* , 2006, European journal of haematology.

[43]  T. Coates,et al.  MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. , 2005, Blood.

[44]  Thomas D. Coates,et al.  Cardiac Iron Determines Cardiac T2*, T2, and T1 in the Gerbil Model of Iron Cardiomyopathy , 2005, Circulation.

[45]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[46]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[47]  D N Firmin,et al.  Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. , 2001, European heart journal.

[48]  G. Sagnella,et al.  Measurement and importance of plasma brain natriuretic peptide and related peptides , 2001, Annals of clinical biochemistry.

[49]  C. Higgins,et al.  Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.

[50]  W. Roberts,et al.  Iron in the heart. Etiology and clinical significance. , 1971, The American journal of medicine.

[51]  OUP accepted manuscript , 2021, European Heart Journal.

[52]  E. Gotsis,et al.  Cardiac magnetic resonance imaging R2* assessments and analysis of historical parameters in patients with transfusion-dependent thalassemia. , 2007, Haematologica.

[53]  Asha Shah,et al.  Thalassemia syndromes. , 2004, Indian journal of medical sciences.

[54]  J. B. Clegg,et al.  The thalassaemia syndromes , 1965 .